赛乐特

目的调查心血管疾病患者中抑郁症的患病率及应用选择性5羟色胺再摄取抑制剂帕罗西汀（赛乐特）的疗效。

Objective To investigate the prevalence of depression in patients with cardiovascular diseases and the effect of Selective Serotonin Reuptake Inhibitor ( Seroxat ) .

干预组在常规治疗的基础上，口服赛乐特20mg/QD，共4周；佳静安定0.2mg/QN，需要时投用。

On the base of conventional therapy , patients of intervention group have taked orally with Seroxat ( 20mg / QD ) and Alprazolanic ( 0.2mg / QN , p.r.n ) .

目的探讨焦点解决短期治疗（SFBT）合用帕罗西汀（赛乐特）对社交恐惧症的临床疗效。

Objective : To evaluate the effect of solution-focused brief therapy ( SFBT ) combined with paroxetine in treatment of social phobia .

赛乐特治疗考前焦虑对成绩的影响研究

Paroxetine Hydrochloride Tablets in the Treatment of Pre-examination Anxiety

赛乐特治疗性病后前列腺炎42例疗效观察

Effect observation on 42 cases of chronic prostatitis after STD treated with Paroxetine

一舒（丁螺环酮）合并赛乐特治疗抑郁症的随机对照研究

A random and controlled study on the united treatment with buspirone and paroxetine for depression

抗抑郁剂对照组单纯给予常规抗抑郁药物帕罗西汀片剂（中美史克天津药业公司生产，批号0401351，商品名赛乐特）进行治疗，20mg/片，20～40mg/d。

The patients in the antidepressant drug group were only given routine antidepressant drug Paroxetine 20 mg per pallet , 20-40 mg daily ( produced by the Tianjin Sino-America Squibb Pharmaceutics Co. , Ltd. No. 0401351 ) .